Scarica l'app Stockscreener
129.79
2.23%
-2.96
Pre-mercato:
129.77
-0.02
-0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BIIB Giù?
Forum
Previsione
Frazionamento azionario
Biogen Inc Borsa (BIIB) Ultime notizie
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
California State Teachers Retirement System Buys 2,811 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. (NASDAQ:BIIB) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Toronto Dominion Bank Has $11.11 Million Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
First County Bank CT Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Farmers Trust Co. Buys 2,012 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
William Blair Brokers Lower Earnings Estimates for Biogen - MarketBeat
Lighthouse Financial LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc (BIIB)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
Centre Asset Management LLC Has $7.79 Million Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Auxier Asset Management Sells 2,136 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Lansforsakringar Fondforvaltning AB publ Invests $7.38 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Mackenzie Financial Corp - MarketBeat
GF Fund Management CO. LTD. Makes New $5.24 Million Investment in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch
Progressive Supranuclear Palsy Treatment Market Set to Witness GrowthBiogen, AbbVie - openPR.com
PKO Investment Management Joint Stock Co Purchases New Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen and City Therapeutics partner to develop RNAi therapies - MSN
Biogen Inc. (NASDAQ:BIIB) Shares Sold by USS Investment Management Ltd - MarketBeat
Siemens Fonds Invest GmbH Grows Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Public Employees Retirement System of Ohio Sells 2,866 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Voloridge Investment Management LLC Invests $23.20 Million in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $234.55 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Tauopathies Treatment Market Detailed in New Research ReportBiogen, AbbVie - openPR.com
Amyotrophic lateral Sclerosis Market 2025-2032: Top Trends & - openPR.com
Recombinant Dna Technology Market Generated Opportunities, - openPR.com
In Vitro Monoclonal Antibodies Market is expected to reach US$ - openPR.com
Biogen and City Therapeutics to develop RNAi therapy - Yahoo Finance
Biogen and City Therapeutics partner to advance RNAi therapies - World Pharmaceutical Frontiers
Biogen Inc. (NASDAQ:BIIB) Holdings Lifted by Quantinno Capital Management LP - MarketBeat
Woodline Partners LP Boosts Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential - Investing.com
Biogen’s SWOT analysis: stock faces challenges amid neuroscience potential By Investing.com - Investing.com UK
Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal - Yahoo Finance
Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal - simplywall.st
Biogen partners with John Maraganore’s new RNAi startup - The Business Journals
Biogen (BIIB) Partners with City Therapeutics for RNAi Therapies - GuruFocus
Biogen strikes RNAi deal with City; Aurion withdraws IPO - BioPharma Dive
City hits the town with $1B-plus deal with Biogen - BioWorld MedTech
Biogen and City Therapeutics collaborate on RNAi meds - The Pharma Letter
Biogen taps City Therapeutics in RNAi deal worth up to $1B - Endpoints News
Biogen (BIIB) Collaborates with City Therapeutics on RNAi Therap - GuruFocus
Biogen and City Therapeutics Announce Strategic Research Collabo - GuruFocus
Biogen (BIIB) Collaborates with City Therapeutics on RNAi Therapies | BIIB Stock News - GuruFocus
Biogen Partners City Therapeutics To Develop Select Novel RNAi Therapies - Nasdaq
Biogen And City Therapeutics Announce Strategic Research Collaboration To Develop Select Novel Rnai-Based Therapies - marketscreener.com
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies | BIIB Stock News - GuruFocus
Biogen Inc. and City Therapeutics Announce Strategic Collaboration to Develop Novel RNAi Therapies - Nasdaq
Biogen and City Therapeutics Announce Strategic Research - GlobeNewswire
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies - Biogen
Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Tidal Investments LLC - MarketBeat
Toronto Dominion Bank Boosts Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat
2,505 Shares in Biogen Inc. (NASDAQ:BIIB) Bought by State of Wyoming - MarketBeat
0.17%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):